🇺🇸 FDA
Patent

US 12178875

Lymphatic system-directing lipid prodrugs

granted A61KA61K45/06A61K47/542

Quick answer

US patent 12178875 (Lymphatic system-directing lipid prodrugs) held by Seaport Therapeutics, Inc. expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Seaport Therapeutics, Inc.
Grant date
Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K45/06, A61K47/542, A61K47/543, A61P